Companies with late-stage small molecules
309 companies hold rights to 358 small molecules (small-molecule drugs, including targeted protein degraders) that are in Phase 3, Phase 2/3 or filed for approval. Sorted by the number of such drugs, then by name. Approved drugs are not counted. The full directory, with financials, is on the companies page.
| Company | Ticker | Late-stage | Drugs (stage, indications) |
|---|---|---|---|
| Jiangsu Hengrui Pharmaceuticals | 600276 | 20 | Apatinib (Phase 3, Non-Small Cell Lung Cancer, Hepatocellular Carcinoma); Dalpiciclib (Phase 3, HR+/HER2- Metastatic Breast Cancer); Famitinib (Phase 3, Non-Small Cell Lung Cancer, Cervical Cancer); Fluzoparib (Phase 3, Metastatic Castration-Resistant Prostate Cancer); Henagliflozin (Phase 3, Type 2 Diabetes, Chronic Kidney Disease); Hetrombopag (Phase 3, Chemotherapy-Induced Thrombocytopenia); HRG2010 (Phase 3, Parkinson's Disease); HRS-1780 (Phase 3, Chronic Kidney Disease); HRS-6209 (Phase 3, HR+/HER2- Metastatic Breast Cancer); HRS-8080 (Phase 3, HR+/HER2- Metastatic Breast Cancer); HRS-8427 (Phase 3, Complicated Urinary Tract Infection); ivarmacitinib (Phase 3, Non-Radiographic Axial Spondyloarthritis); Plinabulin (Phase 3, Non-Small Cell Lung Cancer); Pyrotinib (Phase 3, Non-Small Cell Lung Cancer, HER2-Positive Breast Cancer); Retagliptin (Phase 3, Type 2 Diabetes); Rezvilutamide (Phase 3, Prostate Cancer); RSS0393 (Phase 3, Atopic Dermatitis, Psoriasis); Safiglipron (HRS-7535) (Phase 3, Obesity, Type 2 Diabetes, Hypertension and more); SHR-6209 (Phase 3, HR+/HER2- Metastatic Breast Cancer); SHR6508 (Phase 3, Chronic Kidney Disease) |
| AstraZeneca | AZN | 12 | Balcinrenone (Phase 3, Heart Failure, Chronic Kidney Disease); Ceralasertib (Phase 3); elecoglipron (Phase 3, Obesity, Type 2 Diabetes, Heart Failure and more); Laroprovstat (Phase 3, Atherosclerotic Cardiovascular Disease, Dyslipidemia); laroprovstat/rosuvastatin (Phase 3, Atherosclerotic Cardiovascular Disease); Roxadustat (Phase 3, Chronic Kidney Disease, Myelodysplastic Syndromes); Saruparib (Phase 3, HR+/HER2- Metastatic Breast Cancer, Prostate Cancer); Savolitinib (Phase 3, Non-Small Cell Lung Cancer, Renal Cell Carcinoma); Sodium zirconium cyclosilicate (Phase 3, Chronic Kidney Disease); TQC3721 (Phase 3, Chronic Obstructive Pulmonary Disease); Zibotentan + Dapagliflozin (Phase 3, Chronic Kidney Disease); Glycopyrronium (PT001) (Phase 2/3, Asthma) |
| Merck & Co. | MRK | 9 | Alimatravir (Phase 3, HIV, HIV Pre-Exposure Prophylaxis); Bomedemstat (Phase 3, Essential Thrombocythemia); Calderasib (Phase 3, Non-Small Cell Lung Cancer); Islatravir (Phase 3, HIV); Islatravir/lenacapavir (Phase 3, HIV); Nemtabrutinib (Phase 3, Chronic Lymphocytic Leukemia); Omarigliptin (Phase 3); Opevesostat (Phase 3, Metastatic Castration-Resistant Prostate Cancer); Ulonivirine (Phase 2/3, HIV) |
| Boehringer Ingelheim | — | 7 | Apecotrep (Phase 3, Chronic Kidney Disease, Focal Segmental Glomerulosclerosis); fenoterol (Phase 3, Asthma); fenoterol/ipratropium bromide (Phase 3, Asthma); Ifebemtinib (Phase 3, Non-Small Cell Lung Cancer); Nintedanib (Vargatef) (Phase 3, Non-Small Cell Lung Cancer); Oxitropium bromide (Ba253BINEB) (Phase 3, Asthma); Vicadrostat (Phase 3, Type 2 Diabetes, Hypertension, Heart Failure and more) |
| Pfizer | PFE | 7 | alprostadil (Phase 3, Heart Failure, Atherosclerotic Cardiovascular Disease); Atirmociclib (Phase 3, HR+/HER2- Metastatic Breast Cancer); Esreboxetine (Phase 3, Fibromyalgia); Ibuzatrelvir (Phase 3, COVID-19); Mevrometostat (Phase 3, Metastatic Castration-Resistant Prostate Cancer); Prifetrastat (Phase 3, Non-Small Cell Lung Cancer, HR+/HER2- Metastatic Breast Cancer); Reboxetine (Phase 3, Narcolepsy) |
| Roche | RHHBY | 7 | bexobrutideg (Phase 3, Chronic Lymphocytic Leukemia, Relapsed/Refractory Chronic Lymphocytic Leukemia); Bitopertin (Phase 3, Erythropoietic Protoporphyria); Divarasib (Phase 3, Non-Small Cell Lung Cancer); Fenebrutinib (Phase 3, Multiple Sclerosis); Giredestrant (Phase 3, HR+/HER2- Metastatic Breast Cancer); Bizrolertinib (Phase 2/3, HER2-Positive Breast Cancer); Elsulfavirine (Phase 2/3, HIV) |
| Takeda Pharmaceutical Company | TAK | 7 | Mitiglinide (Phase 3, Type 2 Diabetes); Omega-3-acid ethyl esters 90 (Lotriga) (Phase 3); Osavampator (Phase 3, Major Depressive Disorder); Trelagliptin (Phase 3, Type 2 Diabetes); Voglibose (Phase 3, Type 2 Diabetes); zasocitinib (Phase 3, Psoriatic Arthritis, Psoriasis, Vitiligo and more); TAK-360 (Phase 2/3, Narcolepsy) |
| CSPC Pharmaceutical Group | 1093 | 5 | Ammoxetine (Phase 3, Major Depressive Disorder); Levamlodipine/valsartan (SYH9056) (Phase 3, Hypertension); Prusogliptin (Phase 3, Type 2 Diabetes); Ruserontinib (Phase 3, Acute Myeloid Leukemia); SYHX1901 (Phase 3, Psoriasis) |
| Hansoh Pharmaceutical Group | 3692 | 5 | Almonertinib (Phase 3, Non-Small Cell Lung Cancer); HS-10374 (Phase 3, Psoriatic Arthritis, Psoriasis); HS-10380 (Phase 3, Schizophrenia); SHR6508 (Phase 3, Chronic Kidney Disease); Tenofovir amibufenamide (Hengmu) (Phase 3, Chronic Hepatitis B) |
| Novartis | NVS | 5 | Afuresertib (Phase 3, HR+/HER2- Metastatic Breast Cancer); Ganaplacide/lumefantrine (Phase 3, Malaria); Vildagliptin (Phase 3, Type 2 Diabetes); Votoplam (Phase 3, Huntington's Disease); Zoledronic acid (Phase 3, HR+/HER2- Metastatic Breast Cancer) |
| Qilu Pharmaceutical | — | 5 | Afuresertib (Phase 3, HR+/HER2- Metastatic Breast Cancer); Cariprazine (QLM1016) (Phase 3, Schizophrenia); Iruplinalkib (Phase 3, Non-Small Cell Lung Cancer); Olanzapine/samidorphan (Qilu) (Phase 3, Schizophrenia); QLM3003 (Phase 3, Atopic Dermatitis) |
| Sino Biopharmaceutical | 1177 | 5 | Culmerciclib (Phase 3, HR+/HER2- Metastatic Breast Cancer); Garsorasib (Phase 3, Non-Small Cell Lung Cancer); NTQ1062 (Phase 3, HR+/HER2- Metastatic Breast Cancer); TQC3721 (Phase 3, Chronic Obstructive Pulmonary Disease); TQH3906 (Phase 3, Ulcerative Colitis, Crohn's Disease, Psoriatic Arthritis and more) |
| Taiho Pharmaceutical | — | 5 | Casdatifan (Phase 3, Clear Cell Renal Cell Carcinoma); Glumetinib (Phase 3, Non-Small Cell Lung Cancer); Quemliclustat (Phase 3, Pancreatic Ductal Adenocarcinoma); S-1 (Phase 3, Non-Small Cell Lung Cancer, Colorectal Cancer, Gastric Cancer); Zipalertinib (Phase 3, Non-Small Cell Lung Cancer) |
| A. Menarini | — | 4 | Mirogabalin (Phase 3, Diabetic Peripheral Neuropathic Pain); Obicetrapib (Phase 3, Type 2 Diabetes, Atherosclerotic Cardiovascular Disease, Early Alzheimer's Disease); Obicetrapib/ezetimibe (Evlarco) (Phase 3, Atherosclerotic Cardiovascular Disease); Ranolazine (Phase 3, Atherosclerotic Cardiovascular Disease) |
| Bristol-Myers Squibb | BMY | 4 | Danicamtiv (Phase 3, Heart Failure); Golcadomide (Phase 3, Large B-Cell Lymphoma); Mezigdomide (Phase 3, Multiple Myeloma); Navlimetostat (Phase 2/3, Non-Small Cell Lung Cancer, Pancreatic Ductal Adenocarcinoma) |
| Daewoong Pharmaceutical | 069620 | 4 | DWC202206 + DWC202207 (Phase 3, Hypertension, Atherosclerotic Cardiovascular Disease); Enavogliflozin (Phase 3, Type 2 Diabetes, Chronic Kidney Disease); Gemigliptin (Phase 3, Type 2 Diabetes); Olmesartan/rosuvastatin (DWJ1276) (Phase 3, Hypertension) |
| Eli Lilly | LLY | 4 | Muvalaplin (Phase 3, Atherosclerotic Cardiovascular Disease); Olomorasib (Phase 3, Non-Small Cell Lung Cancer); Tersolisib (Phase 3, HR+/HER2- Metastatic Breast Cancer, Breast Cancer); Cleminorexton (Phase 2/3, Narcolepsy) |
| GlaxoSmithKline | GSK | 4 | neladalkib (Phase 3, Non-Small Cell Lung Cancer, ALK-Positive Non-Small Cell Lung Cancer); Salbutamol HFA-152a (Phase 3, Asthma); Velzatinib (Phase 3, Gastrointestinal Stromal Tumor); Vilanterol (Phase 3, Asthma) |
| Haisco Pharmaceutical Group | 002653 | 4 | Cofrogliptin (Phase 3, Type 2 Diabetes); Crisugabalin (Phase 3, Diabetic Peripheral Neuropathic Pain); HSK39004 (Phase 3, Chronic Obstructive Pulmonary Disease); HSK44459 (Phase 3, Atopic Dermatitis, Psoriasis, Idiopathic Pulmonary Fibrosis) |
| InventisBio | 688382 | 4 | Befotertinib (Phase 3, Non-Small Cell Lung Cancer); Garsorasib (Phase 3, Non-Small Cell Lung Cancer); Nomelcitinib (D-2570) (Phase 3, Ulcerative Colitis, Psoriasis, Systemic Lupus Erythematosus and more); Taragarestrant (Phase 3, HR+/HER2- Metastatic Breast Cancer) |
| Johnson & Johnson | JNJ | 4 | bleximenib (Phase 3, Acute Myeloid Leukemia); Deulumateperone (Phase 3, Alzheimer's Disease, Alzheimer's Disease Agitation, Generalized Anxiety Disorder); JNJ-101556143 (Phase 3, Prostate Cancer); Seltorexant (Phase 3, Alzheimer's Disease, Major Depressive Disorder) |
| JW Pharmaceutical | 001060 | 4 | Anagliptin (Phase 3, Type 2 Diabetes); Enarodustat (Phase 3, Chronic Kidney Disease); JW0201 (Phase 3, Type 2 Diabetes); Mitiglinide (Phase 3, Type 2 Diabetes) |
| Sanofi | SNY | 4 | Gemigliptin (Phase 3, Type 2 Diabetes); Tolebrutinib (Phase 3, Multiple Sclerosis); Venglustat (GZ/SAR402671) (Phase 3, Gaucher Disease); Elenestinib (Phase 2/3, Systemic Mastocytosis) |
| Tanabe Pharma Corporation | — | 4 | AST-120 (Phase 3, Chronic Kidney Disease); Obicetrapib (Phase 3, Type 2 Diabetes, Atherosclerotic Cardiovascular Disease, Early Alzheimer's Disease); Sarpogrelate (Phase 3, Atherosclerotic Cardiovascular Disease); Teneligliptin (Phase 3, Type 2 Diabetes) |
| Allist Pharmaceuticals | 688578 | 3 | Furmonertinib (Phase 3, Non-Small Cell Lung Cancer); Glecirasib (Phase 3, Non-Small Cell Lung Cancer); Sitneprotafib (Phase 3, Non-Small Cell Lung Cancer) |
| Ascentage Pharma Group Inc. | AAPG | 3 | APG-2449 (Phase 3, Non-Small Cell Lung Cancer, Ovarian Cancer); Lisaftoclax (Phase 3, Acute Myeloid Leukemia, Multiple Myeloma, Systemic Lupus Erythematosus and more); Olverembatinib (Phase 3, Acute Myeloid Leukemia, Chronic Myeloid Leukemia, Chronic Myeloid Leukemia with T315I Mutation) |
| Astellas Pharma | 4503 | 3 | Bixalomer (Phase 3, Chronic Kidney Disease, Hyperphosphatemia); Roxadustat (Phase 3, Chronic Kidney Disease, Myelodysplastic Syndromes); Setidegrasib (Phase 3, Non-Small Cell Lung Cancer, Pancreatic Ductal Adenocarcinoma) |
| Beijing InnoCare Pharma Tech Co. | 9969 | 3 | Fadeucravacitinib (Phase 3, Psoriasis); Mesutoclax (Phase 3, Acute Myeloid Leukemia, Mantle Cell Lymphoma, Chronic Lymphocytic Leukemia); Soficitinib (ICP-332) (Phase 3, Atopic Dermatitis, Psoriasis) |
| Betta Pharmaceuticals Co. | 300558 | 3 | Befotertinib (Phase 3, Non-Small Cell Lung Cancer); Icotinib (Phase 3, Non-Small Cell Lung Cancer); Tibremciclib (Phase 3, HR+/HER2- Metastatic Breast Cancer) |
| Biohaven | BHVN | 3 | Troriluzole (Phase 3, Spinocerebellar Ataxia); BHV-8000 (Phase 2/3, Parkinson's Disease); Opakalim (Phase 2/3, Epilepsy, Focal Onset Seizures) |
| China Medical System | 867 | 3 | Desidustat (Phase 3, Chronic Kidney Disease); Piclidenoson (Phase 3, Psoriasis); CMS-D001 (Phase 2/3, Atopic Dermatitis, Psoriasis) |
| Gilead Sciences | GILD | 3 | filgotinib (Phase 3, Rheumatoid Arthritis); Islatravir/lenacapavir (Phase 3, HIV); Quemliclustat (Phase 3, Pancreatic Ductal Adenocarcinoma) |
| Hangzhou Zhongmei Huadong Pharmaceutical | 000963 | 3 | HDM1002 (Phase 3, Obesity, Type 2 Diabetes); janagliflozin (Phase 3, Type 2 Diabetes, Chronic Kidney Disease); VC005 (Phase 3, Atopic Dermatitis) |
| HK inno.N Corporation | 195940 | 3 | Amlodipine/valsartan/atorvastatin (CJ-30061) (Phase 3, Atherosclerotic Cardiovascular Disease); Amlodipine/valsartan/rosuvastatin (CJ-30060) (Phase 3, Hypertension); AST-120 (Phase 3, Chronic Kidney Disease) |
| Luye Pharma Group | 2186 | 3 | Ansofaxine hydrochloride (Phase 3, Major Depressive Disorder); Evogliptin (Phase 3, Type 2 Diabetes); Rotigotine (LY03003) (Phase 3, Parkinson's Disease) |
| Otsuka Holdings | 4578 | 3 | OPC-61815 (Phase 3, Heart Failure); Tolvaptan (Phase 3, Heart Failure, Chronic Kidney Disease); Ulotaront (Phase 3, Schizophrenia, Generalized Anxiety Disorder) |
| Praxis Precision Medicines, Inc. | PRAX | 3 | Relutrigine (Phase 3, Epilepsy, Developmental and Epileptic Encephalopathies); Ulixacaltamide (Phase 3, Essential Tremor); Vormatrigine (Phase 3, Epilepsy, Focal Onset Seizures) |
| Simcere Pharmaceutical | 2096 | 3 | Deulorlatinib (Phase 3, Non-Small Cell Lung Cancer); pumecitinib (Phase 3, Atopic Dermatitis); Zemprocitinib (Phase 3, Atopic Dermatitis, Rheumatoid Arthritis) |
| Advenchen Laboratories | — | 2 | AL8326 (Phase 3, Non-Small Cell Lung Cancer, Small Cell Lung Cancer); Apatinib (Phase 3, Non-Small Cell Lung Cancer, Hepatocellular Carcinoma) |
| Ahn-Gook Pharmaceutical | 001540 | 2 | AG2304 (Phase 3, Atherosclerotic Cardiovascular Disease); AGSAVI (Phase 3, Hypertension) |
| AJU Pharm | — | 2 | Dapagliflozin/linagliptin (Dapalina) (Phase 3, Type 2 Diabetes); Valsartan/amlodipine/chlorthalidone (AJU-C52) (Phase 3, Hypertension) |
| Arcus Biosciences | RCUS | 2 | Casdatifan (Phase 3, Clear Cell Renal Cell Carcinoma); Quemliclustat (Phase 3, Pancreatic Ductal Adenocarcinoma) |
| Ascletis Pharma | 1672 | 2 | ASC30 (Phase 3, Obesity, Type 2 Diabetes); Denifanstat (Phase 3, MASH / NASH, Recurrent Glioblastoma) |
| Avistone Biotechnology | — | 2 | Andamertinib (Phase 3, Non-Small Cell Lung Cancer); Vebreltinib (Phase 3, Non-Small Cell Lung Cancer, Glioma, Non-Small Cell Lung Cancer with MET Exon 14 Skipping) |
| Axsome Therapeutics | AXSM | 2 | Esreboxetine (Phase 3, Fibromyalgia); Reboxetine (Phase 3, Narcolepsy) |
| Bayer | BAYN | 2 | Molidustat (Phase 3, Chronic Kidney Disease); Mosliciguat (Phase 3, Pulmonary Hypertension Associated with Interstitial Lung Disease) |
| BeBetter Med | 688759 | 2 | BEBT-209 (Phase 3, HR+/HER2- Metastatic Breast Cancer, Breast Cancer); Ifupinostat (Phase 3, Multiple Myeloma, Relapsed/Refractory Diffuse Large B-Cell Lymphoma) |
| Boston Oncology | — | 2 | Bireociclib (Phase 3, HR+/HER2- Metastatic Breast Cancer); Dirozalkib (XZP-3621) (Phase 3, Non-Small Cell Lung Cancer) |
| Chengdu Kanghong Pharmaceutical | 002773 | 2 | Cariprazine (Chengdu Kanghong) (Phase 3, Schizophrenia); KH607 (Phase 3, Major Depressive Disorder) |
| Chipscreen Biosciences | 688321 | 2 | Chidamide (Phase 3, Non-Small Cell Lung Cancer, HR+/HER2- Metastatic Breast Cancer, Diffuse Large B-Cell Lymphoma and more); Chiglitazar (Phase 3, Type 2 Diabetes) |
| CSPC ZhongQi Pharmaceutical Technology Co., Ltd. | — | 2 | Docetaxel (HB1801) (Phase 3, Non-Small Cell Lung Cancer, HER2-Positive Breast Cancer); Sirolimus for Injection (Albumin-bound) (Phase 3, HR+/HER2- Metastatic Breast Cancer) |
| Daiichi Sankyo | 4568 | 2 | Esaxerenone (Phase 3, Hypertension); Mirogabalin (Phase 3, Diabetic Peripheral Neuropathic Pain) |
| Dong-A ST | 170900 | 2 | Evogliptin (Phase 3, Type 2 Diabetes); Udenafil (Phase 2/3, Pulmonary Arterial Hypertension) |
| Eurofarma Laboratorios | — | 2 | Evogliptin (Phase 3, Type 2 Diabetes); Rizatriptan/naproxen (Phase 3, Migraine) |
| Exciva GmbH | — | 2 | Deramciclane (Phase 2/3, Alzheimer's Disease); Deraphan (Phase 2/3, Alzheimer's Disease) |
| Genovate Biotechnology | 4130 | 2 | PMR (cilostazol ER) (Phase 3, Atherosclerotic Cardiovascular Disease); Prusogliptin (Phase 3, Type 2 Diabetes) |
| HLB Life Science | 067630 | 2 | Apatinib (Phase 3, Non-Small Cell Lung Cancer, Hepatocellular Carcinoma); Pyrotinib (Phase 3, Non-Small Cell Lung Cancer, HER2-Positive Breast Cancer) |
| HUYABIO International, LLC. | — | 2 | Chidamide (Phase 3, Non-Small Cell Lung Cancer, HR+/HER2- Metastatic Breast Cancer, Diffuse Large B-Cell Lymphoma and more); JMKX001899 (Phase 3, Non-Small Cell Lung Cancer) |
| Incyte | INCY | 2 | INCB123667 (Phase 3, Ovarian Cancer); INCB161734 (Phase 3, Non-Small Cell Lung Cancer, Pancreatic Ductal Adenocarcinoma) |
| Innovent Biologics | 1801 | 2 | Limertinib (Phase 3, Non-Small Cell Lung Cancer); Olverembatinib (Phase 3, Acute Myeloid Leukemia, Chronic Myeloid Leukemia, Chronic Myeloid Leukemia with T315I Mutation) |
| Jacobio Pharmaceuticals | 1167 | 2 | Glecirasib (Phase 3, Non-Small Cell Lung Cancer); Sitneprotafib (Phase 3, Non-Small Cell Lung Cancer) |
| Jiangsu Aosaikang Pharmaceutical | — | 2 | ASKC202 (Phase 3, Non-Small Cell Lung Cancer); Limertinib (Phase 3, Non-Small Cell Lung Cancer) |
| Kissei Pharmaceutical | 4547 | 2 | Mitiglinide (Phase 3, Type 2 Diabetes); Omarigliptin (Phase 3) |
| Kowa Company, Ltd. | — | 2 | Anagliptin (Phase 3, Type 2 Diabetes); Pemafibrate (Phase 3, Atherosclerotic Cardiovascular Disease, Severe Hypertriglyceridemia, Hypertriglyceridemia and more) |
| Lee's Pharmaceutical | 0950 | 2 | Loxapine (Adasuve) (Phase 3, Schizophrenia, Bipolar Disorder); Istaroxime (Phase 2/3, Heart Failure, Cardiogenic Shock in Acute Heart Failure) |
| LG Chem | 051910 | 2 | Besifovir dipivoxil (Besivo) (Phase 3, Chronic Hepatitis B); Gemigliptin (Phase 3, Type 2 Diabetes) |
| Neurocrine Biosciences | NBIX | 2 | Direclidine (Phase 3, Schizophrenia); Osavampator (Phase 3, Major Depressive Disorder) |
| NewAmsterdam Pharma | NAMS | 2 | Obicetrapib (Phase 3, Type 2 Diabetes, Atherosclerotic Cardiovascular Disease, Early Alzheimer's Disease); Obicetrapib/ezetimibe (Evlarco) (Phase 3, Atherosclerotic Cardiovascular Disease) |
| Reistone Biopharma | — | 2 | ivarmacitinib (Phase 3, Non-Radiographic Axial Spondyloarthritis); RSS0393 (Phase 3, Atopic Dermatitis, Psoriasis) |
| Sanwa Kagaku Kenkyusho | — | 2 | Anagliptin (Phase 3, Type 2 Diabetes); Upacicalcet (Phase 3, Chronic Kidney Disease, Secondary Hyperparathyroidism) |
| Servier | — | 2 | Darovasertib (Phase 3, Uveal Melanoma); Teneligliptin (Phase 3, Type 2 Diabetes) |
| Shanghai Fosun Pharmaceutical Industrial Development Co. Ltd. | 600196 | 2 | Foritinib succinate (Phase 3, Non-Small Cell Lung Cancer); Luvometinib (Phase 3, Non-Small Cell Lung Cancer, Glioma) |
| Shenzhen Salubris Pharmaceuticals | 002294 | 2 | Enarodustat (Phase 3, Chronic Kidney Disease); SAL0120 (Phase 3, Hypertension, Chronic Kidney Disease) |
| Shionogi | 4507 | 2 | Dalcetrapib (Phase 3, Atherosclerotic Cardiovascular Disease); Enarodustat (Phase 3, Chronic Kidney Disease) |
| Sunshine Lake Pharma | — | 2 | Clifutinib Besylate (Phase 3, Acute Myeloid Leukemia); Mitizodone phosphate (Phase 2/3, Major Depressive Disorder) |
| vTv Therapeutics | VTVT | 2 | cadisegliatin (Phase 3, Type 1 Diabetes); Prifemilast (HPP737) (Phase 3, Psoriasis) |
| Xuanzhu Biopharmaceutical | 2575 | 2 | Bireociclib (Phase 3, HR+/HER2- Metastatic Breast Cancer); Dirozalkib (XZP-3621) (Phase 3, Non-Small Cell Lung Cancer) |
| Zydus Lifesciences | ZYDUSLIFE | 2 | Desidustat (Phase 3, Chronic Kidney Disease); Saroglitazar (Phase 3, Type 2 Diabetes, Hypertriglyceridemia, Primary Biliary Cholangitis) |
| Aardvark Therapeutics | — | 1 | ARD-101 (Phase 3, Obesity, Prader-Willi Syndrome) |
| AB Science | AB | 1 | Masitinib (Phase 3, Alzheimer's Disease, Asthma, Amyotrophic Lateral Sclerosis and more) |
| Abivax | ABVX | 1 | obefazimod (Phase 3, Ulcerative Colitis, Crohn's Disease) |
| Acadia Pharmaceuticals | ACAD | 1 | Remlifanserin (Phase 3, Alzheimer's Disease, Alzheimer's Disease Psychosis) |
| Aclipse Therapeutics | — | 1 | Lobeglitazone (Phase 3, Type 2 Diabetes) |
| Actinogen Medical (ASX: ACW) | ACW | 1 | Emestedastat (Phase 2/3, Alzheimer's Disease, Major Depressive Disorder) |
| Addpharma | — | 1 | AD-209 (Phase 3, Hypertension) |
| AffaMed Therapeutics | — | 1 | fasedienol (Phase 3, Social Anxiety Disorder) |
| AgeneBio | — | 1 | AGB101 (Phase 2/3, Alzheimer's Disease) |
| Agyany Pharma Ltd | — | 1 | Ambroxol (Phase 3, Parkinson's Disease) |
| AirNexis Therapeutics | — | 1 | HSK39004 (Phase 3, Chronic Obstructive Pulmonary Disease) |
| Aldeyra Therapeutics | ALDX | 1 | reproxalap (Phase 3, Dry Eye Disease, Allergic Conjunctivitis) |
| Alebund Pharmaceuticals | 9637 | 1 | AP301 (fiber-iron phosphate binder) (Phase 3, Chronic Kidney Disease, Hyperphosphatemia) |
| Alfasigma | — | 1 | filgotinib (Phase 3, Rheumatoid Arthritis) |
| Alkem Laboratories | ALKEM | 1 | Evogliptin (Phase 3, Type 2 Diabetes) |
| Alkermes plc | ALKS | 1 | Alixorexton (Phase 3, Narcolepsy, Idiopathic Hypersomnia) |
| Almirall | ALM | 1 | Dimethyl fumarate (Skilarence) (Phase 3, Psoriasis) |
| Alpha Biopharma (Jiangsu) Co., Ltd. | — | 1 | Zorifertinib (Phase 2/3, Non-Small Cell Lung Cancer) |
| Alumis | ALMS | 1 | Envudeucitinib (Phase 3, Psoriasis, Systemic Lupus Erythematosus) |
| Amgen | AMGN | 1 | Bixalomer (Phase 3, Chronic Kidney Disease, Hyperphosphatemia) |
| Amorepacific | — | 1 | asivatrep (Phase 3, Atopic Dermatitis) |
| Anavex Life Sciences | AVXL | 1 | Blarcamesine (Phase 2/3, Alzheimer's Disease) |
| Angel Pharmaceuticals | — | 1 | soquelitinib (Phase 3, Atopic Dermatitis, Peripheral T-Cell Lymphoma) |
| Annovis Bio (NYSE American: ANVS) | ANVS | 1 | Buntanetap (Phase 3, Alzheimer's Disease, Parkinson's Disease, Early Alzheimer's Disease) |
| Apollomics Inc. | APLM | 1 | Vebreltinib (Phase 3, Non-Small Cell Lung Cancer, Glioma, Non-Small Cell Lung Cancer with MET Exon 14 Skipping) |
| Aquestive Therapeutics, Inc. | AQST | 1 | Diazepam (Libervant) (Phase 3, Epilepsy) |
| Arcera Life Sciences | — | 1 | Enavogliflozin (Phase 3, Type 2 Diabetes, Chronic Kidney Disease) |
| AriBio | — | 1 | AR1001 (Phase 3, Alzheimer's Disease) |
| Arog Pharmaceuticals, Inc. | — | 1 | Crenolanib (Phase 3, Acute Myeloid Leukemia) |
| ArriVent BioPharma | AVBP | 1 | Furmonertinib (Phase 3, Non-Small Cell Lung Cancer) |
| Bausch Health | BHC | 1 | Rifaximin SSD (Phase 3) |
| Beijing Biostar Pharmaceuticals | 2563 | 1 | Utidelone (Phase 3, Non-Small Cell Lung Cancer, HR+/HER2- Metastatic Breast Cancer) |
| BeOne Medicines | ONC | 1 | BGB-43395 (Phase 3, HR+/HER2- Metastatic Breast Cancer) |
| Beta Pharma, Inc. | — | 1 | Rezivertinib (Phase 3, Non-Small Cell Lung Cancer) |
| BeyondSpring Pharmaceuticals | BYSI | 1 | Plinabulin (Phase 3, Non-Small Cell Lung Cancer) |
| BioCity Biopharmaceutics | — | 1 | SC0062 (Phase 3, Chronic Kidney Disease) |
| Biogen | BIIB | 1 | BIIB122 / DNL151 (LRRK2 inhibitor) (Phase 3, Parkinson's Disease) |
| Biopeutics | — | 1 | alprostadil (Phase 3, Heart Failure, Atherosclerotic Cardiovascular Disease) |
| BioVie Inc. (NASDAQ: BIVI) | BIVI | 1 | Bezisterim (Phase 3, Alzheimer's Disease, Parkinson's Disease) |
| BioXcel Therapeutics, Inc. | BTAI | 1 | Dexmedetomidine (Igalmi) (Phase 3, Schizophrenia, Bipolar Disorder, Alzheimer's Disease Agitation) |
| Boryung Pharmaceutical | 003850 | 1 | Fimasartan/atorvastatin/ezetimibe (BR1017) (Phase 3, Hypertension, Atherosclerotic Cardiovascular Disease) |
| cAMPfield Therapeutics | — | 1 | Prifemilast (HPP737) (Phase 3, Psoriasis) |
| Can-Fite BioPharma | CANF | 1 | Piclidenoson (Phase 3, Psoriasis) |
| CellCentric Ltd. | — | 1 | Inobrodib (Phase 3, Acute Myeloid Leukemia, Multiple Myeloma) |
| Cerecin (Singapore, formerly Accera, Nestle Health Science-backed) | — | 1 | Tricaprilin (Phase 3, Alzheimer's Disease) |
| Cerevance | — | 1 | Solengepras (CVN424) (Phase 3, Parkinson's Disease) |
| Chendu DIAO Pharmaceutical Group | — | 1 | DA-302168S (Phase 3, Obesity, Type 2 Diabetes) |
| Chengdu Easton Biopharmaceuticals | — | 1 | Yogliptin (Phase 3, Type 2 Diabetes) |
| Chengdu Zenitar Biomedical Technology | — | 1 | Purinostat Mesylate (Phase 3, Multiple Myeloma, Diffuse Large B-Cell Lymphoma) |
| Chia Tai Tianqing Pharmaceutical Group | — | 1 | Lanifibranor (Phase 3, Type 2 Diabetes, MASH / NASH) |
| Chiesi Farmaceutici | — | 1 | Beclomethasone dipropionate/formoterol fumarate (Phase 3, Chronic Obstructive Pulmonary Disease, Asthma) |
| China Resources Double-Crane Pharmaceutical | 600062 | 1 | Gemigliptin (Phase 3, Type 2 Diabetes) |
| Chong Kun Dang Pharmaceutical | 185750 | 1 | Lobeglitazone (Phase 3, Type 2 Diabetes) |
| Cipla | CIPLA | 1 | Vildagliptin (Phase 3, Type 2 Diabetes) |
| Cogent Biosciences, Inc. | COGT | 1 | bezuclastinib (Phase 3, Systemic Mastocytosis, Gastrointestinal Stromal Tumor) |
| COMPASS Pathways | CMPS | 1 | Psilocybin (COMP360) (Phase 3, Major Depressive Disorder, Post-Traumatic Stress Disorder) |
| Corvus Pharmaceuticals | CRVS | 1 | soquelitinib (Phase 3, Atopic Dermatitis, Peripheral T-Cell Lymphoma) |
| Corxel Pharmaceuticals | — | 1 | Omecamtiv mecarbil (Phase 3, Heart Failure, Heart Failure with Reduced Ejection Fraction) |
| CSPC Ouyi Pharmaceutical Co. | — | 1 | SYHX1901 (Phase 3, Psoriasis) |
| Cullinan Therapeutics Inc. | CGEM | 1 | Zipalertinib (Phase 3, Non-Small Cell Lung Cancer) |
| Cytokinetics | CYTK | 1 | Omecamtiv mecarbil (Phase 3, Heart Failure, Heart Failure with Reduced Ejection Fraction) |
| DalCor Pharmaceuticals | — | 1 | Dalcetrapib (Phase 3, Atherosclerotic Cardiovascular Disease) |
| Definium Therapeutics | DFTX | 1 | Lysergide tartrate (LSD) (Phase 3, Major Depressive Disorder, Attention Deficit Hyperactivity Disorder, Generalized Anxiety Disorder) |
| Denali Therapeutics | DNLI | 1 | BIIB122 / DNL151 (LRRK2 inhibitor) (Phase 3, Parkinson's Disease) |
| Dermavon Holdings | — | 1 | CMS-D001 (Phase 2/3, Atopic Dermatitis, Psoriasis) |
| Desitin Arzneimittel GmbH | — | 1 | Piribedil (Clarium) (Phase 3, Parkinson's Disease) |
| Disc Medicine | IRON | 1 | Bitopertin (Phase 3, Erythropoietic Protoporphyria) |
| Dr. Reddy's Laboratories | RDY | 1 | Pyrotinib (Phase 3, Non-Small Cell Lung Cancer, HER2-Positive Breast Cancer) |
| EA Pharma | — | 1 | Upacicalcet (Phase 3, Chronic Kidney Disease, Secondary Hyperparathyroidism) |
| Eccogene | — | 1 | elecoglipron (Phase 3, Obesity, Type 2 Diabetes, Heart Failure and more) |
| Eikon Therapeutics | EIKN | 1 | Resiquimod (Phase 2/3, Non-Small Cell Lung Cancer, Melanoma) |
| Eisai | 4523 | 1 | Mitiglinide (Phase 3, Type 2 Diabetes) |
| Elevar Therapeutics, Inc. | — | 1 | Apatinib (Phase 3, Non-Small Cell Lung Cancer, Hepatocellular Carcinoma) |
| Eton Pharmaceuticals, Inc. | ETON | 1 | Diazepam (Libervant) (Phase 3, Epilepsy) |
| Everest Medicines (Beijing) Co., Ltd. | 1952 | 1 | Sumecigrel (Phase 3, Atherosclerotic Cardiovascular Disease) |
| Exelixis | EXEL | 1 | Zanzalintinib (Phase 3, Non-Small Cell Lung Cancer, Clear Cell Renal Cell Carcinoma, Colorectal Cancer and more) |
| Ferrer Internacional | — | 1 | Loxapine (Adasuve) (Phase 3, Schizophrenia, Bipolar Disorder) |
| Fuji Pharma Co., Ltd. | 4554.T | 1 | Colestilan (Phase 3, Chronic Kidney Disease) |
| G42 Healthcare | — | 1 | cadisegliatin (Phase 3, Type 1 Diabetes) |
| Gebro Pharma GmbH | — | 1 | Piclidenoson (Phase 3, Psoriasis) |
| GenFleet Therapeutics | 2595 | 1 | GFH375 (Phase 3, Non-Small Cell Lung Cancer, Pancreatic Ductal Adenocarcinoma) |
| Geropharm | — | 1 | Evogliptin (Phase 3, Type 2 Diabetes) |
| Glenmark Pharmaceuticals Ltd. | GLENMARK | 1 | Almonertinib (Phase 3, Non-Small Cell Lung Cancer) |
| GNT Biotech & Medicals | — | 1 | Chidamide (Phase 3, Non-Small Cell Lung Cancer, HR+/HER2- Metastatic Breast Cancer, Diffuse Large B-Cell Lymphoma and more) |
| Gossamer Bio | GOSS | 1 | Seralutinib (Phase 3, Pulmonary Arterial Hypertension) |
| Grace Therapeutics | GRCE | 1 | Nimodipine (GTx-104) (Phase 3, Subarachnoid Hemorrhage) |
| Guangzhou JOYO Pharma | — | 1 | Fudotinib (Phase 3, Non-Small Cell Lung Cancer) |
| H. Lundbeck | HLUN.B | 1 | Bexicaserin (Phase 3, Epilepsy) |
| Haihe Biopharma | — | 1 | Glumetinib (Phase 3, Non-Small Cell Lung Cancer) |
| Handok | 002390 | 1 | Teneligliptin (Phase 3, Type 2 Diabetes) |
| Hangzhou Highlightll Pharmaceutical | — | 1 | BHV-8000 (Phase 2/3, Parkinson's Disease) |
| Harmony Biosciences | HRMY | 1 | Clemizole (EPX-100) (Phase 3, Epilepsy, Dravet Syndrome, Lennox-Gastaut Syndrome) |
| Helus Pharma | HELP | 1 | Deupsilocin (Phase 3, Major Depressive Disorder) |
| Henan Genuine Biotech | — | 1 | Azvudine (Phase 3, HIV, COVID-19) |
| HighTide Biopharma | 2511 | 1 | Berberine ursodeoxycholate (HTD1801) (Phase 3, Type 2 Diabetes, Atherosclerotic Cardiovascular Disease) |
| Hua Medicine | 2552 | 1 | Dorzagliatin (Phase 3, Type 2 Diabetes) |
| Huadong Medicine | 000963 | 1 | Edaravone (TTYP01) (Phase 3, Alzheimer's Disease, Acute Ischemic Stroke) |
| HUTCHMED | HCM | 1 | Savolitinib (Phase 3, Non-Small Cell Lung Cancer, Renal Cell Carcinoma) |
| IDEAYA Biosciences | IDYA | 1 | Darovasertib (Phase 3, Uveal Melanoma) |
| IlDong Pharmaceutical Co., Ltd. | 249420 | 1 | Besifovir dipivoxil (Besivo) (Phase 3, Chronic Hepatitis B) |
| Immuneering Corporation | IMRX | 1 | Atebimetinib (Phase 3, Non-Small Cell Lung Cancer, Pancreatic Cancer) |
| Immunome, Inc. | IMNM | 1 | Varegacestat (Phase 2/3, Desmoid Tumors) |
| Inhibikase Therapeutics | IKT | 1 | Imatinib mesylate prodrug (IkT-001Pro) (Phase 3, Pulmonary Arterial Hypertension) |
| Intra-Cellular Therapies | — | 1 | Deulumateperone (Phase 3, Alzheimer's Disease, Alzheimer's Disease Agitation, Generalized Anxiety Disorder) |
| Inventiva | IVA | 1 | Lanifibranor (Phase 3, Type 2 Diabetes, MASH / NASH) |
| InxMed | — | 1 | Ifebemtinib (Phase 3, Non-Small Cell Lung Cancer) |
| Jazz Pharmaceuticals | JAZZ | 1 | Cannabidiol (JZP926) (Phase 2/3, Epilepsy) |
| Jeil Pharmaceutical | — | 1 | Pioglitazone (JT-001) (Phase 3, Type 2 Diabetes) |
| Jemincare | — | 1 | JMKX001899 (Phase 3, Non-Small Cell Lung Cancer) |
| Ji Xing Pharmaceuticals (CORXEL) | — | 1 | VCT220 (Phase 3, Obesity, Type 2 Diabetes, Hypertension) |
| Jiangsu Aidea Pharmaceutical Group | — | 1 | ACC017 (Phase 3, HIV) |
| Jiangsu Chia Tai Fenghai Pharmaceutical Co., Ltd. | — | 1 | FHND9041 (Phase 3, Non-Small Cell Lung Cancer) |
| Jiangsu Vcare Pharmaceutical Technology Co., Ltd. | — | 1 | Sumecigrel (Phase 3, Atherosclerotic Cardiovascular Disease) |
| Jiangsu Vcare Pharmatech | — | 1 | VC005 (Phase 3, Atopic Dermatitis) |
| Jilin Huisheng Biopharmaceutical | — | 1 | janagliflozin (Phase 3, Type 2 Diabetes, Chronic Kidney Disease) |
| Kailera Therapeutics | KLRA | 1 | Safiglipron (HRS-7535) (Phase 3, Obesity, Type 2 Diabetes, Hypertension and more) |
| Kaken Pharmaceutical | 4521 | 1 | Envudeucitinib (Phase 3, Psoriasis, Systemic Lupus Erythematosus) |
| Kardigan | KARD | 1 | Danicamtiv (Phase 3, Heart Failure) |
| Kind Pharmaceuticals | — | 1 | AND017 (Phase 3, Chronic Kidney Disease, Myelodysplastic Syndromes) |
| Korea United Pharm | 033270 | 1 | Cilostazol/rosuvastatin (UI022/UI023) (Phase 3, Atherosclerotic Cardiovascular Disease) |
| Kureha Corporation | 4023 | 1 | AST-120 (Phase 3, Chronic Kidney Disease) |
| Kyntra Bio | KYNB | 1 | Roxadustat (Phase 3, Chronic Kidney Disease, Myelodysplastic Syndromes) |
| Laboratoires SMB S.A. | — | 1 | Pravafenix (Phase 3, Atherosclerotic Cardiovascular Disease, Hypertriglyceridemia) |
| Laekna Limited | 2105 | 1 | Afuresertib (Phase 3, HR+/HER2- Metastatic Breast Cancer) |
| LB Pharmaceuticals | LBRX | 1 | LB-102 (methylated amisulpride) (Phase 3, Major Depressive Disorder, Schizophrenia) |
| Linnaeus Therapeutics, Inc. | — | 1 | LNS8801 (Phase 2/3, Non-Small Cell Lung Cancer, Melanoma) |
| Liquidia Corporation | LQDA | 1 | Treprostinil (L606) (Phase 3, Pulmonary Arterial Hypertension, Pulmonary Hypertension Associated with Interstitial Lung Disease) |
| Lynk Pharmaceuticals | — | 1 | Zemprocitinib (Phase 3, Atopic Dermatitis, Rheumatoid Arthritis) |
| Maia Biotechnology | MAIA | 1 | Ateganosine (THIO) (Phase 3, Non-Small Cell Lung Cancer) |
| Matinas BioPharma | MTNB | 1 | Amphotericin B (MAT2203) (Phase 3, Cryptococcal Meningitis) |
| MediciNova, Inc. | MNOV | 1 | Ibudilast (Phase 2/3, Asthma, Amyotrophic Lateral Sclerosis) |
| Medix | — | 1 | Tesofensine (Phase 3, Obesity) |
| Meiji Seika Pharma | — | 1 | Chidamide (Phase 3, Non-Small Cell Lung Cancer, HR+/HER2- Metastatic Breast Cancer, Diffuse Large B-Cell Lymphoma and more) |
| Mezzion Pharma | 140410 | 1 | Udenafil (Phase 2/3, Pulmonary Arterial Hypertension) |
| MindRank AI | — | 1 | MDR-001 (Phase 3, Obesity) |
| Mineralys Therapeutics | MLYS | 1 | Lorundrostat (Phase 3, Hypertension, Chronic Kidney Disease) |
| Minerva Neurosciences | NERV | 1 | Roluperidone (Phase 3, Schizophrenia) |
| Moleculin | MBRX | 1 | Annamycin (Phase 2/3, Acute Myeloid Leukemia) |
| Nanjing Sanhome Pharmaceutical | — | 1 | Rilertinib (SH-1028) (Phase 3, Non-Small Cell Lung Cancer) |
| NeuroDerm Ltd. | — | 1 | Levodopa/carbidopa (ND0612) (Phase 3, Parkinson's Disease) |
| Newsoara Biopharma | — | 1 | Prifemilast (HPP737) (Phase 3, Psoriasis) |
| Ningbo/Zhejiang Wenda Pharma Technology Co. | — | 1 | WD-890 (Phase 3, Psoriasis) |
| Nizhpharm | — | 1 | Chidamide (Phase 3, Non-Small Cell Lung Cancer, HR+/HER2- Metastatic Breast Cancer, Diffuse Large B-Cell Lymphoma and more) |
| Nordic Group B.V. | — | 1 | S-1 (Phase 3, Non-Small Cell Lung Cancer, Colorectal Cancer, Gastric Cancer) |
| Nova Pneuma Inc. | — | 1 | Staccato Alprazolam (Phase 3, Epilepsy) |
| NRx Pharmaceuticals | NRXP | 1 | D-cycloserine/lurasidone (NRX-101) (Phase 3, Major Depressive Disorder, Bipolar Depression) |
| Nurix Therapeutics, Inc. | NRIX | 1 | bexobrutideg (Phase 3, Chronic Lymphocytic Leukemia, Relapsed/Refractory Chronic Lymphocytic Leukemia) |
| Nuvalent, Inc. | — | 1 | neladalkib (Phase 3, Non-Small Cell Lung Cancer, ALK-Positive Non-Small Cell Lung Cancer) |
| Nuvation Bio | NUVB | 1 | safusidenib (Phase 3, Glioma) |
| Nxera Pharma | 4565 | 1 | Direclidine (Phase 3, Schizophrenia) |
| OCULAR THERAPEUTIX, INC | OCUL | 1 | Axitinib intravitreal implant (OTX-TKI) (Phase 3, Age-Related Macular Degeneration, Wet Age-Related Macular Degeneration) |
| Olema Pharmaceuticals, Inc. | OLMA | 1 | Palazestrant (Phase 3, HR+/HER2- Metastatic Breast Cancer) |
| Ono Pharmaceutical | 4528 | 1 | ONO-4578 (Phase 3, Non-Small Cell Lung Cancer, Gastric Cancer) |
| ORIC Pharmaceuticals | ORIC | 1 | Rinzimetostat (Phase 3, Prostate Cancer) |
| Orion Corporation | ORNBV | 1 | Levosimendan (Phase 3, Heart Failure, Pulmonary Hypertension due to Left Heart Disease) |
| Pathalys Pharma | — | 1 | Upacicalcet (Phase 3, Chronic Kidney Disease, Secondary Hyperparathyroidism) |
| PegBio | 2565 | 1 | PB-201 (Phase 3, Type 2 Diabetes) |
| Pharma Two B Ltd. | — | 1 | Pramipexole/rasagiline (P2B001) (Phase 3, Parkinson's Disease) |
| PharmaMar | PHM | 1 | Plitidepsin (Phase 3, Multiple Myeloma) |
| Pharmanovia | — | 1 | Diazepam (Libervant) (Phase 3, Epilepsy) |
| Pharmosa Biopharm Inc. | 6875 | 1 | Treprostinil (L606) (Phase 3, Pulmonary Arterial Hypertension, Pulmonary Hypertension Associated with Interstitial Lung Disease) |
| Population Council | — | 1 | Dapivirine (Phase 3, HIV) |
| Prime Gene Therapeutics | — | 1 | pumecitinib (Phase 3, Atopic Dermatitis) |
| Priothera SAS | — | 1 | mocravimod (Phase 3, Acute Myeloid Leukemia) |
| Provectus Pharmaceuticals | PVCT | 1 | rose bengal disodium (Phase 3, Locally Advanced Cutaneous Melanoma) |
| PTC Therapeutics | PTCT | 1 | Vatiquinone (PTC743) (Phase 3, Friedreich Ataxia) |
| Pulmovant | — | 1 | Mosliciguat (Phase 3, Pulmonary Hypertension Associated with Interstitial Lung Disease) |
| Quetzal Therapeutics | — | 1 | Arsenic trioxide (QTX-2101) (Phase 3, Acute Myeloid Leukemia) |
| Rapport Therapeutics, Inc. | RAPP | 1 | RAP-219 (Phase 3, Epilepsy, Focal Onset Seizures) |
| Rednvia | — | 1 | Evogliptin (Phase 3, Type 2 Diabetes) |
| Relay Therapeutics, Inc. | RLAY | 1 | Zovegalisib (Phase 3, HR+/HER2- Metastatic Breast Cancer) |
| Revolution Medicines | RVMD | 1 | Zoldonrasib (Phase 3, Non-Small Cell Lung Cancer, Pancreatic Cancer) |
| Risen (Suzhou) Pharma Tech Co., Ltd. | — | 1 | JS105 (Phase 3, HR+/HER2- Metastatic Breast Cancer) |
| Roivant Sciences Ltd. | ROIV | 1 | Mosliciguat (Phase 3, Pulmonary Hypertension Associated with Interstitial Lung Disease) |
| Sagimet Biosciences Inc. | SGMT | 1 | Denifanstat (Phase 3, MASH / NASH, Recurrent Glioblastoma) |
| Saniona | SANION | 1 | Tesofensine (Phase 3, Obesity) |
| SatRx | — | 1 | Gosogliptin (Phase 3, Type 2 Diabetes) |
| SDK Therapeutics | — | 1 | Arsenic trioxide (SDK001) (Phase 3, Acute Myeloid Leukemia) |
| Seismic Pharma | — | 1 | Istaroxime (Phase 2/3, Heart Failure, Cardiogenic Shock in Acute Heart Failure) |
| SFA Therapeutics | — | 1 | SFA-002 (Phase 2/3, Psoriasis) |
| Shanghai Auzone Biological Technology | — | 1 | Edaravone (TTYP01) (Phase 3, Alzheimer's Disease, Acute Ischemic Stroke) |
| Shanghai Fosun Pharmaceutical (Group) Co., Ltd. | 600196 | 1 | AR1001 (Phase 3, Alzheimer's Disease) |
| Shanghai Green Valley Pharmaceuticals | — | 1 | Sodium oligomannate (Phase 3, Alzheimer's Disease) |
| Shanghai Henlius Biotech | 2696 | 1 | FHND9041 (Phase 3, Non-Small Cell Lung Cancer) |
| Shanghai Junshi Bioscience | 1877 | 1 | JS105 (Phase 3, HR+/HER2- Metastatic Breast Cancer) |
| Shanghai Longwood Biopharmaceuticals | — | 1 | LW402 (Phase 3, Atopic Dermatitis) |
| Shanghai Pharmaceuticals Holding | 2607 | 1 | SPH4336 (Phase 2/3, HR+/HER2- Metastatic Breast Cancer) |
| Shenyang Sunshine Pharmaceutical | — | 1 | Clifutinib Besylate (Phase 3, Acute Myeloid Leukemia) |
| Shenzhen TargetRx | — | 1 | Deulorlatinib (Phase 3, Non-Small Cell Lung Cancer) |
| Shijiazhuang Yiling Pharmaceutical Co. Ltd | 002603 | 1 | XY0206 (Phase 3, Acute Myeloid Leukemia) |
| Sihuan Pharmaceutical Holdings | 0460 | 1 | janagliflozin (Phase 3, Type 2 Diabetes, Chronic Kidney Disease) |
| SK Biopharmaceuticals Co., Ltd. | 326030 | 1 | Carisbamate (Phase 3, Epilepsy) |
| Soligenix | SNGX | 1 | Synthetic hypericin (Phase 3) |
| Specialised Therapeutics | — | 1 | Plitidepsin (Phase 3, Multiple Myeloma) |
| Spinogenix | — | 1 | Tazbentetol (SPG302) (Phase 2/3, Alzheimer's Disease, Schizophrenia, Amyotrophic Lateral Sclerosis) |
| STADA Arzneimittel | — | 1 | Trigel (Phase 3, Parkinson's Disease) |
| Stendhal | — | 1 | Gemigliptin (Phase 3, Type 2 Diabetes) |
| Structure Therapeutics | GPCR | 1 | aleniglipron (Phase 3, Obesity, Type 2 Diabetes) |
| Sumitomo Pharma | 4506 | 1 | Vildagliptin (Phase 3, Type 2 Diabetes) |
| Suven Life Sciences | SUVEN | 1 | Masupirdine (Phase 3, Alzheimer's Disease) |
| Suzhou Puhe Pharmaceutical Technology Co., LTD | — | 1 | Pruvonertinib (Phase 3, Non-Small Cell Lung Cancer) |
| Suzhou Zelgen Biopharmaceuticals | 688266 | 1 | jaktinib (Phase 3, Atopic Dermatitis, Myelofibrosis, Alopecia Areata) |
| T's Pharma | — | 1 | Voglibose (Phase 3, Type 2 Diabetes) |
| T3D Therapeutics | — | 1 | T3D-959 (Phase 2/3, Alzheimer's Disease) |
| TauRx Therapeutics | — | 1 | Hydromethylthionine mesylate (Phase 3, Alzheimer's Disease) |
| Teijin | 3401 | 1 | Trelagliptin (Phase 3, Type 2 Diabetes) |
| Tempest Therapeutics | TPST | 1 | Amezalpat (Phase 3, Hepatocellular Carcinoma) |
| Tenacia Biotechnology | — | 1 | RAP-219 (Phase 3, Epilepsy, Focal Onset Seizures) |
| Tenax Therapeutics | TENX | 1 | Levosimendan (Phase 3, Heart Failure, Pulmonary Hypertension due to Left Heart Disease) |
| Teva Pharmaceutical Industries | TEVA | 1 | Dexmedetomidine (Igalmi) (Phase 3, Schizophrenia, Bipolar Disorder, Alzheimer's Disease Agitation) |
| Tianjin Hemay Pharmaceutical | — | 1 | Mufemilast (Phase 3, Ulcerative Colitis, Psoriasis) |
| TransThera Sciences (Nanjing), Inc. | 2617 | 1 | Tinengotinib (Phase 3, HR+/HER2- Metastatic Breast Cancer, Cholangiocarcinoma) |
| Trevi Therapeutics, Inc. | TRVI | 1 | Nalbuphine ER (Phase 3, Prurigo Nodularis, Chronic Cough in Idiopathic Pulmonary Fibrosis) |
| TYK Medicines, Inc. | 2410 | 1 | Asandeutertinib (Phase 3, Non-Small Cell Lung Cancer) |
| UCB | UCBJY | 1 | Staccato Alprazolam (Phase 3, Epilepsy) |
| United Therapeutics | UTHR | 1 | Ralinepag (Phase 3, Pulmonary Arterial Hypertension) |
| Vanda Pharmaceuticals | VNDA | 1 | tradipitant (Phase 3, Gastroparesis) |
| Verastem, Inc. | VSTM | 1 | GFH375 (Phase 3, Non-Small Cell Lung Cancer, Pancreatic Ductal Adenocarcinoma) |
| Vertex Pharmaceuticals | VRTX | 1 | Inaxaplin (Phase 2/3, Chronic Kidney Disease, APOL1-Mediated Kidney Disease) |
| Vifor Pharma | — | 1 | Patiromer (Phase 3, Chronic Kidney Disease) |
| Vimgreen Pharmaceuticals | — | 1 | VG081821AC (Phase 2/3, Parkinson's Disease) |
| Vincentage Pharma | — | 1 | VCT220 (Phase 3, Obesity, Type 2 Diabetes, Hypertension) |
| Viriom | — | 1 | Elsulfavirine (Phase 2/3, HIV) |
| VistaGen Therapeutics | VTGN | 1 | fasedienol (Phase 3, Social Anxiety Disorder) |
| VIVUS | — | 1 | Extended-release tacrolimus (VI-0106) (Phase 3, Pulmonary Arterial Hypertension) |
| Wuhan Createrna Science and Technology | — | 1 | QR12000 (Phase 3, Hypertension) |
| Xenon Pharmaceuticals | XENE | 1 | Azetukalner (Phase 3, Major Depressive Disorder, Epilepsy, Focal Onset Seizures and more) |
| Yuhan Corporation | 000100 | 1 | Sarpogrelate (Phase 3, Atherosclerotic Cardiovascular Disease) |
| Zeria Pharmaceutical Co., Ltd. | 4559 | 1 | Patiromer (Phase 3, Chronic Kidney Disease) |
| Zhejiang Hisun Pharmaceutical | 600267 | 1 | Hyzetimibe (Phase 3, Atherosclerotic Cardiovascular Disease) |
| Zhimeng Biopharma | — | 1 | CB03-154 (Phase 2/3, Epilepsy, Amyotrophic Lateral Sclerosis) |
Stage is the furthest stage the drug has reached in any indication. Kind follows each drug's recorded modality; a drug whose modality is not recorded is left out.